Report cover image

Regenerative Therapies Market

Publisher Coherent Market Insights
Published Jun 30, 2023
Length 178 Pages
SKU # CMI18107819

Description

Regenerative Therapies Market, By Tissue Type (Allograft, Xenograft, Alloplast), By Application type (Soft Tissue Repair, Cardiovascular, Dental, Orthoped, CNS disease treatment,Others), By End user (Hospitals, Ambulatory Surgical Centers, Educational Institutes), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030


Regenerative medicine is one the fastest emerging fields of medicine, as it adopts stem cells for treatment. Increasing age or injury, makes it difficult to provide the optimum amount of stem cells that are needed to maintain the normal function. The goal of regenerative medicine is to amplify this natural repair system to keep pace with the demands of the patients. Orthopedics is one of the fields of regenerative medicine, which adopts natural healing process by stimulating regeneration of cells in the musculoskeletal system. Histogen Inc. is one of the manufacturer of orthopedic regenerative medicine and its product Human Extracellular matrix (hECM) is anti-inflammatory, angiogenic, and can stimulate growth of stem cells in damaged areas to induce tissue regeneration.

Market Dynamics

The regenerative therapy market is witnessing rapid expansion due to the increasing demand for innovative treatments that can restore and regenerate damaged tissues and organs. Market dynamics are being shaped by advancements in stem cell therapies, tissue engineering, and gene therapy, which are driving the market's growth. Despite challenges related to cost and regulatory complexities, continuous technological advancements and growing investments in research and development are driving the market forward. As awareness grows and clinical evidence accumulates, the regenerative therapy market is poised to transform healthcare by offering transformative solutions and improving patient outcomes.

Restraints of the Global Regenerative Therapies Market

Lack of standardized guidelines on tissue and bio-medical engineering is expected to hinder growth of the global regenerative therapies market. Moreover, lengthy clinical trials leading to delayed entry of products in the market is expected to restrain growth of the market.

Key features of the study:
  • This report provides in-depth analysis of the global regenerative therapies market and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global regenerative therapies market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Shire Pharmaceuticals, Kinetic Concepts, Inc., Mesoblast Ltd., Metcela Inc., Nuo Therapeutics (Cytomedix Inc.), Integra LifeSciences, Advanced Cell Technology Inc., BioStem Life Sciences,Akron Biotechnology, LLC, Organovo Holdings Inc., Orgenesis Inc., Pluristem Therapeutics Inc., Genzyme, Athersys, Inc., RenovaCare, Inc., Cytori Therapeutics, Inc.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global regenerative therapies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation:
  • Global Regenerative Therapies Market, By Tissue Type:
  • Allograft
  • Xenograft
  • Alloplast
  • Global Regenerative Therapies Market, By Application:
  • Soft Tissue Repair
  • Cardiovascular
  • Dental
  • Orthopedic
  • CNS disease treatment
  • Others
  • Global Regenerative Therapies Market, By End User:
  • Hospitals
  • Ambulatory Surgical Centers
  • Educational Institutes
  • Global Regenerative Therapies Market, By Geography:
  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
  • Shire Pharmaceuticals
  • Kinetic Concepts, Inc.
  • Mesoblast Ltd.
  • Metcela Inc.
  • Nuo Therapeutics (Cytomedix Inc.)
  • Integra LifeSciences
  • Advanced Cell Technology, Inc.
  • BioStem Life Sciences
  • Akron Biotechnology, LLC
  • Organovo Holdings Inc.
  • Orgenesis Inc.
  • Pluristem Therapeutics Inc.
  • Genzyme
  • Athersys, Inc.
  • RenovaCare, Inc.
  • Cytori Therapeutics, Inc.

Table of Contents

178 Pages
1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Tissue Type
Market Snippet, By Application
Market Snippet, By End User
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Developments
Regulatory Scenario
PEST Analysis
COVID-19 Impact
4. Global Regenerative Therapies Market, By Tissue Type, 2023 - 2030(US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030(%)
Y-o-Y Growth Analysis, 2018–2030
Segment Trends
Allograft
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Xenograft
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Alloplast
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
5. Global Regenerative Therapies Market, By Application, 2023 - 2030(US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030(%)
Y-o-Y Growth Analysis, 2018–2030
Segment Trends
Soft Tissue Repair
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Cardiovascular
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Dental
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Orthopedic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
CNS disease treatment
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
6. Global Regenerative Therapies Market, By End User, 2023 - 2030(US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030(%)
Y-o-Y Growth Analysis, 2018 - 2030
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Ambulatory Surgical Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Educational Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
7. Global Regenerative Therapies Market, By Regions, 2023 - 2030(US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030(%)
Y-o-Y Growth Analysis, 2018 - 2030
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
North Africa
Central Africa
South Africa
8. Competitive Landscape
Company Profiles
Shire Pharmaceuticals
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Kinetic Concepts, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Mesoblast Ltd.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Metcela Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Nuo Therapeutics (Cytomedix Inc.)
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Integra LifeSciences
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Advanced Cell Technology, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
BioStem Life Sciences
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Akron Biotechnology, LLC
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Organovo Holdings Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Orgenesis Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Pluristem Therapeutics Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Genzyme
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Athersys, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
RenovaCare, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Cytori Therapeutics, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 31 market data tables and 23 figures on “Regenerative Therapies Market – Global forecast to 2027.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us